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The acylation reactions employing Fmoc-amino acid chlorides have been carried out in the presence of AgCN.
There is no addition of any base. The coupling is fast and racemization free. The work up and the isolation of
products are easy. Thus the synthesis of several dipeptides, a model tetrapeptide, Leu-Ala-G1y-Val and ~-
casomorphin (Tyr-Pro-Phe-Pro-Gly) are accomplished.
Although the use of acid chlorides in peptide
synthesis has long been regarded as obsolete.v" 9-
fluorenylmethoxycarbonyl (Fmoc)-amino acid
chlorides now appear to serve as efficient coupling
reagents for peptide bond formation following the
stepwise strategy''". Fmoc-amino acid chlorides
possessing benzyl group have been found to be
stable for long period and can be easily prepared.
They are shown to be useful in a novel method of
rapid, repetitive peptide synthesis. Acylation
reactions employing them have to be carried out in
the presence of a base. A biphasic system like 5%
Na2CO) or 10% NaHC03/CH2Clz has been used for
coupling in the solution phase. Instead, an organic
base like diisopropylethylamine, triethylamine,
pyridine or N-methylmorpholine has been tried but
this leads to the conversion of the acid chloride to
the corresponding oxazolone formation.
Consequently, the coupling was carried out using a
base and l-hydroxybenzotriazole (HOBt).
Alternatively, the acylation reactions using acid
chlorides can also be accomplished in presence of
potassium salt of HOBt8.
It was reported" that sterically hindered esters
can be prepared from their corresponding acyl
chlorides and alcohols using silver cyanide as a
catalyst which is superior to the conventional acyl
chloride-alcohol-pyridine method as regards yield
and the rapidity of reaction. Rich et al. 10, employed
AgCN as a catalyst for the preparation of the
sterically hindered Fmoc-N-MeVal-OBut using
Fmoc-N-MeVal-CI and t-butyl alcohol. Freidinger
et alii., used AgCN as a co-coupling agent for the
introduction of dehydropiperazic acid during the
solid phase synthesis of cyclichexapeptide
oxytocin agonists.
The present paper describes the coupling of
Fmoc-amino acid chlorides in the presence of
AgCN in solution phase. The general procedure for
coupling involves the treatment of equimolar
quantities of an amino acid ester/peptide ester with
Fmoc-amino acid chloride and AgCN. The reaction
mixture was refluxed with stirring at 60° and the
progress of the reaction was monitored by TLC.
The reaction was complete within 10-15 min. No
other addition of base was required during
coupling. Thus several dipeptide esters containing
simple as well as sterically hindered amino acids
have been prepared. The HPLC profile of crude
dipeptide ester, Fmoc-Ala-Val-OBzl is given in
Figure 1. The acylation reactions in the presence of
AgCN as catalyst was found to significantly
enhance the rate of coupling. It may be due to the
increase in the electrophilicity of acid chloride.
This method appears promising for the synthesis of
peptides possessing steric hinderance in the amino
cOI?ponent (Table I).
The IH NMRI2 spectra of Tos-Phg-Ala-OMe [8
3.50 (s, OCH3)] and Tos-D-Phg-Ala-OMe [8 3.61
(s, OCH3)], prepared by this method, demonstrated
that the coupling is free from racemization. Further
this method is used for the synthesis of peptides for
extending the chain from C-terrninal to N-terrninal
by following the stepwise strategy. Thus the
synthesis of the model tetrapeptide, Leu-Ala-Gly-
Val and the opioid pentapeptide p-casomorphin
(Tyr-Pro-Phe-Pro-Gly) have been accomplished
(Scheme I). The protected tetrapeptide Fmoc-Leu-
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Ala-Gly-Val-OBzI and the protected pentapeptide
~-casomorphin [Fmoc-Tyr(BzI)-Pro-Phe-Pro-Gly-
Obzl] were converted to free peptides by catalytic
transfer hydrogenation (CTH) using Pd black/85%
formic acid. The purity of the free peptides was
checked by HPLC (Figures 2 and 3). An yield of
85% of the tetrapeptide and 50~ of ~-casomorphin
was obtained.However, several attempts made to
couple Fmoc-Sar-C1 with Sar-OMe/OBzI were
unsuccessful. It resulted in less yield and pure
crystalline peptides could not be isolated.
Experimental Section
All amino acids used except Gly and Sar, have
the L-configuration. Melting points were
determined using a Leitz-Wetzlar apparatus and
are uncorrected. TLC analysis was carried out
using the precoated silica gel G plates using i)
CHCh: methanol: acetic acid:: 40:2:1; ii) CHCh:
methanol :: 9: 1; iii) n-butanol : acetic acid : water
:: 4:1:1; iv) n-butanol : acetic acid: water :: 4:1:5
and the R, values are designated as R, A, Rf B, R, C
and R, D respectively. Elemental analysis was
carried out after drying the compounds for 24 hr at
50° in vacuo. Amino acid analysis was carried out
with a Waters HPLC system using a PICO-TAG
column (3.9 mm x 30 em) after hydrolysing the
Figure I-Analytical RP-HPLC of Fmoc-Ala-Val-OBzI;
Deltapak C-I8 column (3.9 mm x 300 mm was used);
flowrate: 0.40 mlImin; UV monitoring at 220 nm; eluant:
isocratic 65% methanol in water.
Table I-Protected dipeptide esters
Peptide * Yield M.p. Rj values [a]2SD Mol. formula Found (Calc) %
% (0C) RrA RrB C H N
Fmoc-Ala- Val- 80 112-15 0.56 0.77 + 18.5 C30H32N20S 72.10 6.3 5.70
OBzl (c I, CH2CI2) (72.00) (6.4) (5.6)
Fmoc-Phe-Leu- 85 155-57 0.82 0.71 + 24 C37H38N20S 75.12 6.51 4.66
OBzI (c I, CHCh) (75.25) (6.44) (4.74)
Fmoc-Leu- Val- 75 125-28 0.7~ 0.63 + 11.8 C33H38N20S 74.\0 6.8 5.20
OBzI (c 0.5, CHCI3) (73.06) (7.0) (5.16)
Tos-Phg-Ala-OCH3 70 201-03 0.56 0.68 +60.0 CI9H22N20S S 58.20 5.10 7.40
(c I, CHCI3) (58.46) (5.64) (7.1)
Tos-D-Phg-Ala- 75 174-76 0.55 0.66 - 64.0 CI9H22N20S S 58.20 5.10 7.40
OCH3 (c I, CHCI3) (58.46) (5.64) (7.1)
Fmoc-N-Pgy-Sar- 60 142-45 0.45 0.68 + 20.2 C33H~20S 73.80 5.70 5.40
OBzI (c I, CHCI3) (74.15) (5.61) (5.2)
Fmoc-Ile-Sar-OBzI 65 Gum 0.50 0.72 -52.6 C31H34N20S 72.12 6.80 5.30
(c 0.5, CHCI3) (72.33) (6.61) (5.44)
Fmoc-Sar-Ile-OBzI 60 Gum 0.47 0.70 - 42.4 C31H34N20S 72.12 6.70 5.20
(c 0.5, CHCI3) (72.33) (6.61) (5.44)
Fmoc-Gly- Val- 80 184-86 0.52 0.68 - 20.9 C29H~20S 76.20 6.10 6.20
OBzI (c I, CHCh) (76.54) (6.17) (5.76)
Fmoc-Pro-Gly- 75 75 0.58 0.74 + 27.7 C29H28N20S 72.00 6.1 5.60
OBzI (c I, CH2CI2) (71.9) (5.9) (5.7)
*Abbreviations used for amino acids are in accordance with the recommendations of the IUPAC-IUB Commission on
Biochemical Nomenclature published in 'Pure and Applied Chemistry', 40, 1974, 314. Additional ones used are Sar, sarcosine;
Phg, a-aminophenylacetic acid (a-phenylglycine); N-Pgy, N-phenylgIycine.
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Scheme I-Schematic representation of the synthesis of ~-casomorphin using appropriate
Fmoc-amino acid chloride! AgCN in toluene medium.
peptides using 6 N HCI at 110° for 24 hr. Optical
rotations were measured with an automatic digital
AA-1O polarimeter (Optical Activity, U.K.). The
HPLC system (Waters) consisted of two pumps
(model 501), 484 tunable UV detector and a 820
peak integration system.
Synthesis of pep tides using Fmoc-amino acid
chlorides/ AgCN : General procedure. To a
solution of amino acid ester/peptide acid ester (l
mmole) in toluene (3 mL) was added a solution of
Fmoc-amino acid chloride (l mmole) and AgCN (l
mmole) in toluene (3 mL) and the mixture. was
refluxed with stirring for 10-15 min at 60°C. The
mixture was then washed thrice with 15 mL
portions of 5% NaHC03, 5% HCI, water, saturated
NaCI solution and dried over Na2S04. The organic
layer was evaporated in vacuo and recrystallisation
of oily residue from suitable solvent gave the
product in good yield and purity.
General procedure for deprotection of Fmoc-
group using 4-aminomethylpiperidine (4-AMP).
A solution of the Fmoc-N-protected peptide ester
(0.75 mmole) in CH2Ch (5 mL) was treated with 4-
AMP (5 mL). After 30 min (completion of
deprotection was determined by TLC), CH2Cl2 (30
mL) was added and the solution was washed with
phosphate buffer (pH 5.5, prepared from 90 g of








Figure 2-HPLC profile of Leu-Ala-Gla-Val [Waters CIK
deltapak column (3.9 mm x 30 ern, 15 11, spherical); flow rate:
0.8 ml/min; UV monitoring at 210 nm; eluant: 60% CH3CN-
H20 (0.1 % trifluoroacetic acid)].
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Figure 3-Analytical RP-HPLC of pure ~-casomorphin:
waters C-18 deltapak column (3.9 mm x 300 mm, 15~); flow
rate: Iml/min; eluant A: 0.1 % TFA in H20, B: 0.1 % TFA in
CH3CN; linear gradient 15-40% Bin 20 min.
of distilled water) and then with saturated NaCI
solution. The organic phase was dried over anhyd.
Na2S04. Evaporation of solvent in vacuo and
recrystallisation of the residue using suitable
solvent gave the product in good yield.
Synthesis of Leu-Ala-Gly-Val : Fmoc-Gly-
Val-OBzl 1. A mixture of valine benzyl ester p-
toluenesulfonic acid salt (0.800 g, 2 mmole) in 6
mL of toluene and NEt3 (few drops) was coupled
with Fmoc-Gly-CI (0.636 g, 2 mmole) and AgCN
(0.266 g, 2 mmole) in toluene (6 mL) following the
general procedure for coupling. Recrystallization
of the peptide using CH2Clrhexane gave the
product, yield 0.820 g (80%), m.p. 184-86°C; RfA,
0.52; RfB, 0.72; [a]250-20.9° (c 1, CHCh).
Gly-Val-OBzI2. Fmoc-Gly-Val-OBzl (1, 0.729
g, 1.5 mmole) was N-deproteCted following the
general procedure for deprotection of Fmoc group
using 4-AMP (10 mL) to yield 0.340 g (86%) of
the free peptide 2, m.p. 202-205°C; RrC, 0.50; RfD,
0.38; [a]250-12.8o (c 1, CHCh).
Fmoc-Ala-Gly-Val-OBzl 3. A solution of
Fmoc-Ala-CI (0.395 g, 1.2 mmole) and AgCN
(0.160 g, 1.2 mmole) in toluene (4 mL) was
coupled with peptide 3 (0.316 g, 1.2 mmole) in
toluene (4 mL) to yield the peptide 3, yield 0.490 g
(73%), m.p. 140-42°C; RfA, 0.45 ; RfB, 0.68;
[a]25o+ 33.50 (c 1, CH2Ch).
A1a-Gly- Val-OBzI 4. Fmoc-Ala-Gly- Val-OBzI
(3, 0.450 g, 0.9 mmole) was N-deprotected using
4-AMP (6 mL) to get the title peptide 4, yield
0.220 g (81%), m.p. 105-108°C; RrC, 0.33; RfD,
0.25; [a]25o -26.40 (c 0.5, CHCh).
Fmoc-Leu-A1a-Gly-Val-OBzl 5. Peptide 5
(0.168 g, 0.5 mmole) in toluene (2 mL) was
coupled with Fmoc~Leu-CI (0.185 g, 0.5 mmole)
and AgCN (0.101 mg, 0.76 mmole) in toluene (2
mL) to yield 0.220 g (66%) of.the title peptide 5,
m.p. 130-32°C; RrC, 0.43; RfD, 0.75; [a]25o + 40°
(c 1, CHCh).
Leu-Ala-Gly-Val 6. Fmoc and benzyl groups in
peptide 5 were removed by CTH. To a solution of
the protected peptide 5 (0.1 g, 1 mmole) in anhyd.
methanol (0.5 mL), 85% HCOOH (1.0 mL) and
palladium black (0.07 g) were added and stirred at
room temperature for 3 hr. The completion of the
reaction was monitored by TLC. The catalyst was
filtered off and washed with hot methanol. The
combined filtrate was evaporated in vacuo and the
residue after trituration with ether to dissolve 9-
methylfluorene, was precipitated using methanol-
ether to obtain the peptide salt, Leu-Ala-Gly-Val.
HCOOH, yield 0.06 g (85%). The peptide salt was
then stirred with water (1 mL) and aq. NaHC03
(2%, 5 mL) for 20 rnin and extracted with EtOAc
(3 x 40 mL). The organic layer was evaporated in
vacuo to get the free tetrapeptide 6, m.p. 142-43°C;
[a]25o + 22.5° (c 1, ethanol), RrC, 0.33; RfD, 0.35
[Reported'", m.p. 140-43°C; [a]25o + 22° (c 1,
ethanol); RrC, 0.32; RfD, 0.36]. Anal. Found: C,
53.42; H, 8.2; N, 15.82. Calc. for C16H3oN405
(358.72) : C, 53.57; H, 8.43; N, 15.69%. Amino
acid analysis: (Calc.), Found: Leu (1) 0.98, Ala
(1) 0.96, Gly (1) 0.96, Va(l) 1.01.
Synthesis of J3-casomorphin : Fmoc-Pro-Gly-
OBzl 7. A mixture of glycine benzyl ester p-
toluene sulfonic acid salt (1.071 g, 3 mmole) in
toluene (9 mL) and NEt3 (few drops) was reacted
with Fmoc-Pro-Cl (1.068 g, 3 mmole) and AgCN
(0.399 g) in toluene (9 mL) to get the dipeptide 7,
yield 1.050 g (72%), m.p. 60-62°C; RtA, 0.58; RfB,
0.74; [a]25o+ 27.7° (c 1, CH2Ch).
Pro-Gly-OBzl (8). Following the general
procedure for deprotection, compound 7 (0.900 g,
1.8 mmole) was N-deprotected using 4-AMP (12
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mL) to yield 0.420 g (86%) of the title peptide 8,
m.p. 108-100C; ReA. 0.34; ReB, 0.44; [af5o - 60.5°
(c 0.5, CHCh).
Fmoc-Phe-Pro-Gly-OBzl 9. A solution of
Fmoc-Phe-Cl (0.630 g, 1.5 mmole) and AgCN
(0.198 g, 1.5 mmole) in toluene (6 mL) was reacted
with peptide 8 (0.414 g, 1.6 mmole) in toluene (6
mL) to yield the peptide 9, yield 0.630 g (64%),
m.p. 146-48°C; [a]25o - 41.2° (c 1, CHCh).
Phe-Pro-Gly-OBzl 10. The cleavage of Fmoc
group from peptide 9 (0.471 g, 0.75 mmole) using
4-AMP (6 mL) led to 0.255 g (84%) of the peptide
10, m.p. 188-90°C; RfA, 0.27; RfB, 0.34; [a]25D_
30.8° (c 1, CHCh).
Fmoc-Pro-Phe-Pro-Gly-Oflzl 11. A solution
of Fmoc-Pro-Cl (0.480 g, 1.35 mmole) and AgCN
(0.198 g, 1.5 mmole) in toluene (6 mL) was reacted
with pep ide 10 (0.552 g, 1.35 minole) in toluene (6
mL) to yield 0.780 g (79%) of peptide 11, m.p.
120°C; ReA, 0.59; ReB, 0.72; [a]25o - 60.2 (c 1,
CHCh).
Pro-Phe-Pro-Gly-OBzl 12. The cleavage of
Fmoc-group from the peptide 11 (0.435 g, 0.6
mmole) by using 4-AMP (3 mL) led to 0.240 g
(80%) of the peptide 12, m.p. 175-77°C; RfA, 0.29;
Rc.B,0.38.
Fmoc- Tyr(BzI)-Pro-Phe-Pro-Gly-OBzl 13. A
solution of Fmoc-Tyr(Bzl)-CI (0.16 g, 0.3 mmole)
and AgCN (0.039 g) in toluene (3 mL) was reacted
with peptide 12 (0.150 g, 0.3 mmole) in toluene (6
mL) to yield 0.213 g (72%) of the peptide 13, m.p.
160-61°C; ReA, 0.60; ReB, 0.73; [af5o - 80 (c 0.5,
CHCh).
Tyr-Pro-Phe-Pro-Gly 14. The N-protected
peptide ester 13 (0.200 g, 0.2 mmole) was
subjected to CTH using palladium black (0.140 g)
and 85% HCOOH (2 mL) in anhyd. MeOH (1 mL).
After workup, the free pentapeptide Tyr-Pro-Phe-
Pro-Gly was isolated, yield 0.600 g (50%), m.p.
151-53°; [a]25o - 48.5° (c 0.5, dimethylformamide),
RtC, 0.40 [(Reported16m.p. 152-54°; [a]250_ 48° (c
0.5, dimethylformamide); RcC, 0.42]. Anal. Found:
C, 62.69; H 6.02; N, 12.28. Calc. For C30H35N507
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(578) : C, 62.34; H, 6.10; N, 12.17%. Amino
acid analysis: (Calc.) Found': Gly(1) 1.00; Pro (2)
2.12; Phe (1) 0.98; Tyr(1) 0.97. The synthetic
peptide exhibited the biological activities. similar to
that of the natural molecule.
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